Form 4: Vera Therapeutics CFO Sean Grant Reports Changes in Beneficial Ownership

Sean Grant, CFO of Vera Therapeutics, reports changes in beneficial ownership of Class A Common Stock due to gifts and transactions through trusts and custodial accounts.

Summary

• On March 14, 2023, Sean Grant gifted 14,285 shares of Class A Common Stock, resulting in a decrease in direct holdings and an increase in trust holdings.
• On July 24, 2023, there was a gift of 1,620 shares of Class A Common Stock into a trust.
• On December 20, 2023, there was a gift of 636 shares of Class A Common Stock into a trust.
• The report also details shares held indirectly through a trust, an IRA, a Roth IRA, a spouse's IRA, and a custodial account for a family member.

Sentiment

Score: 5

Explanation: This is a neutral report on changes in beneficial ownership, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.

Stakeholder Impact

• Shareholders are informed about the CFO's transactions in company stock.
• The filing ensures transparency and compliance with SEC regulations.

Key Dates